Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
Abstract Background Metastatic breast cancer (BCa) is most often diagnosed months after completion of treatment of the primary tumor when a patient reports physical symptoms.Besides a physical examination, no other alternative recurrence screening method is recommended for routine follow-up care.Detection of autoantibodies against tumor-associated